These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7452004)
1. In vivo or in vitro modulating effects of vincristine on the generation of allogeneic cytotoxic lymphocytes in vitro. Bartocci A; Riccardi C; Bonmassar E J Immunopharmacol; 1980; 2(1):61-72. PubMed ID: 7452004 [TBL] [Abstract][Full Text] [Related]
2. Amplification of natural killer activity of mouse lymphocytes by vincristine. De Vecchis L; Pastore S; Migliorati G; Bonmassar Giuliani A; Frati L Int J Tissue React; 1982; 4(4):283-9. PubMed ID: 6220991 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease. Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029 [TBL] [Abstract][Full Text] [Related]
4. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells. Gillis S; Smith KA J Exp Med; 1977 Aug; 146(2):468-82. PubMed ID: 69003 [TBL] [Abstract][Full Text] [Related]
5. In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo. Romani L; Fioretti MC; Bonmassar E Transplantation; 1979 Sep; 28(3):218-22. PubMed ID: 494379 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin. Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340 [TBL] [Abstract][Full Text] [Related]
7. Haplotype-specific suppression of antibody responses in vitro. I. Generation of genetically restricted suppressor T cells by neonatal treatment with semiallogeneic spleen cells. Sorensen CM; Pierce CW J Exp Med; 1981 Jul; 154(1):35-47. PubMed ID: 6454756 [TBL] [Abstract][Full Text] [Related]
8. H-2 I alloantigens and recall of memory cytotoxic responses. Orosz CG; Macphail S; Bach FH J Supramol Struct; 1980; 14(1):121-7. PubMed ID: 6971370 [TBL] [Abstract][Full Text] [Related]
9. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers. Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602 [TBL] [Abstract][Full Text] [Related]
10. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro. Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374 [TBL] [Abstract][Full Text] [Related]
11. Acquisition of multiple drug resistance by CCRF-CEM cells selected for different degrees of resistance to vincristine. Conter V; Beck WT Cancer Treat Rep; 1984 Jun; 68(6):831-9. PubMed ID: 6539648 [TBL] [Abstract][Full Text] [Related]
12. In vitro induction of cell-mediated immunity to murine leukemia cells. III. Effect of methanol extraction residue fraction of BCG on the generation of cytotoxic lymphocytes against leukemia. Kedar E; Nahas F; Unger E; Weiss DW J Natl Cancer Inst; 1978 May; 60(5):1097-106. PubMed ID: 147948 [TBL] [Abstract][Full Text] [Related]
13. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo. Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224 [TBL] [Abstract][Full Text] [Related]
14. Allosuppression of B cells in vitro by graft-vs.-host reaction-derived T cells is caused by cytotoxic T lymphocytes. Rozendaal L; Pals ST; Schilham M; Melief CJ; Gleichmann E Eur J Immunol; 1989 Sep; 19(9):1669-75. PubMed ID: 2792183 [TBL] [Abstract][Full Text] [Related]
15. Effects of cholera toxin on the lymphoid system. III. In vivo generation of cytotoxic lymphocytes. Tsuru S; Nomoto K; Oka M; Zinnaka Y J Clin Lab Immunol; 1983 Apr; 10(4):209-14. PubMed ID: 6602889 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells. Nogae I; Kikuchi J; Yamaguchi T; Nakagawa M; Shiraishi N; Kuwano M Br J Cancer; 1987 Sep; 56(3):267-72. PubMed ID: 3663474 [TBL] [Abstract][Full Text] [Related]
17. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570). Liepins A; Nowicky JW Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312 [TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive effect of concanavalin-A. I. Suppression of generation of cytotoxic lymphocytes in MLC. Wasik M Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):327-30. PubMed ID: 155433 [TBL] [Abstract][Full Text] [Related]
19. Vincristine increases the genomic instability in irradiated cultured human peripheral blood lymphocytes. Jagetia GC; Shrinath Baliga M Toxicol Lett; 2002 Feb; 126(3):179-86. PubMed ID: 11814706 [TBL] [Abstract][Full Text] [Related]
20. Genetic control of the immune response to myoglobins. Both low and high responder T cells tolerant to the other major histocompatibility complex help high but not low responder B cells. Kohno Y; Berzofsky JA J Exp Med; 1982 Sep; 156(3):791-809. PubMed ID: 6213732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]